N-Nitroso Edoxaban Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Edoxaban is used to prevent stroke and blood clots in patients with a certain heart rhythm problem (eg, nonvalvular atrial fibrillation). Edoxaban is also used to treat deep venous thrombosis, a condition in which harmful blood clots form in the blood vessels of the legs.N-Nitroso Edoxaban Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Edoxaban Impurity 1 chemically represented as 5-nitroso-4,5,6,7- tetrahydrothiazolo[5,4-c] pyridin-2-amine.Synchemia is the leading manufacturing and exporter of N-Nitroso Edoxaban Impurity 1 .We supply N-Nitroso Edoxaban Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0143572 |
| CAS No | NA |
| Mol.F. | C6H3FN4O2 |
| Mol.Wt. | 182.11g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143573 |
| CAS No | NA |
| Mol.F. | C15H23N3O5 |
| Mol.Wt. | 325.4g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0143574 |
| CAS No | NA |
| Mol.F. | C15H23N3O5 |
| Mol.Wt. | 325.4g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143575 |
| CAS No | NA |
| Mol.F. | C15H22N4O6 |
| Mol.Wt. | 354.36 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143576 |
| CAS No | NA |
| Mol.F. | C12H15N5O5 |
| Mol.Wt. | 309.28 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143577 |
| CAS No | NA |
| Mol.F. | C10H15N3O4 |
| Mol.Wt. | 241.25 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143578 |
| CAS No | NA |
| Mol.F. | C12H15ClN2O5 |
| Mol.Wt. | 302.71 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143579 |
| CAS No | NA |
| Mol.F. | C14H20N4O6 |
| Mol.Wt. | 340.34 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0143580 |
| CAS No | NA |
| Mol.F. | C17H25N3O7 |
| Mol.Wt. | 383.40 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143581 |
| CAS No | NA |
| Mol.F. | C12H16BrN3O5 |
| Mol.Wt. | 362.18 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143582 |
| CAS No | NA |
| Mol.F. | C11H10N4O3 |
| Mol.Wt. | 246.23 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143583 |
| CAS No | NA |
| Mol.F. | C13H14N4O3 |
| Mol.Wt. | 274.28 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143584 |
| CAS No | NA |
| Mol.F. | C14H17N5O3 |
| Mol.Wt. | 303.32 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143585 |
| CAS No | NA |
| Mol.F. | C4H11N3O |
| Mol.Wt. | 117.09g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143586 |
| CAS No | NA |
| Mol.F. | C19H26N4O8S4 |
| Mol.Wt. | 566.7 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143587 |
| CAS No | 72782-14-0 |
| Mol.F. | C5H11N3O |
| Mol.Wt. | 129.2 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |